SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock price rallies, sparking discussions about a potential short squeeze and a test of all-time highs, with some traders anticipating a move towards $500. Community members are debating the sustainability of the rally, citing factors like EV tax credit expiration and Elon Musk's influence, while others point to strong European sales and potential robotaxi expansion news as bullish catalysts. The stock's high valuation and potential manipulation are also hot topics.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending amid speculation of a potential investment from Apple, with community members discussing the implications for Intel's foundry business and its competitive positioning against TSMC. The surge follows positive sentiment around government support and a recent investment from Nvidia, fueling discussions about Intel's turnaround and future growth prospects. Optimism is high, with some anticipating significant gains and a return to prominence in the chip manufacturing sector.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending as investors are actively discussing its potential in the AI cloud infrastructure space, with some drawing comparisons to other high-growth stocks and data center plays. Community members are pointing to analyst upgrades and the company's strategic shift towards AI, while also debating valuation and potential pullbacks. Bullish sentiment appears strong, fueled by increasing interest in AI infrastructure and data centers.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

Shares of uniQure are surging after positive data from its Huntington's disease therapy trial, with analysts highlighting the potential for this treatment to be a 'diamond in the rough' for biotech. The community is buzzing about the significant slowing of disease progression and potential for accelerated FDA approval. Some traders are also discussing the possibility of a near-term offering.

Plinko Incinerator is a Solana-based utility platform that allows users to burn unwanted tokens, NFTs, and dust from their wallets, reclaiming the associated SOL. This reduces wallet clutter and unlocks value from previously worthless assets. The platform also features a gamified system where reclaimed SOL can be used to play a custom Plinko game with real payout mechanics. $PLINC is the governance and utility token that powers the platform, offering reduced fees, staking, governance rights, and exclusive access to future features.

PlinkoIncinerator

PlinkoIncinerator ($PLINC.X) is trending as traders discuss increased volume and potential breakouts, particularly within the Solana ecosystem. Community members are actively monitoring price action and transfers using Phantom Wallet. Sentiment suggests an early accumulation phase with bulls stepping in, fueling speculation about future gains.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

IMRX is trending due to positive clinical trial data showing an extraordinary survival rate for pancreatic cancer patients, sparking optimism and discussion about its potential. Community members are weighing the impact of a concurrent public offering and private placement with Sanofi, debating whether the positive data will outweigh concerns about dilution. Some traders are pointing to the company's unique mechanism of action, potential for buyout and comparing it to other high-flying stocks without options chains.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco's upcoming earnings report is a key catalyst, with the community closely watching consumer spending trends and guidance, especially amid inflation and tariff concerns. Discussions also involve the impact of DEI policies and the potential for a stock split. Some analysts point to stretched valuations and technical bearish signals, while others remain bullish, citing strong membership loyalty and potential for market share gains.

Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.

Eason Technology Ltd. - ADR

Eason Technology Ltd ADR

DXF is trending as traders discuss the potential of its low float and past performance, drawing comparisons to other China-based stocks that have recently experienced significant gains. Community members are actively analyzing recent filings and speculating on upcoming news, particularly regarding a potential crypto treasury strategy. Some traders believe DXF could be primed for a substantial upward move if it gains momentum.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: North America Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, Rod and Refining, Atlantic Copper Smelting and Refining, and Corporate and Other. The North America Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The Rod and Refining segment consists of copper conversion facilities located in North America and includes a refinery and rod mills. The Atlantic Copper Smelting and Refining segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

FCX is trending due to concerns and discussions around a mud rush at the Grasberg mine, impacting production estimates and prompting a significant stock drop. The community is weighing the potential for a class action lawsuit, the long-term effects on production, and the market's overreaction versus the underlying strength of copper prices. Some traders see this dip as a buying opportunity, while others express bearish sentiment, highlighting the uncertainty surrounding the mine's full recovery and its potential impact on the company's financials.

Fusion Fuel Green Plc engages in the research and development of solar technologies. It develops a process and technology to produce emission-free green hydrogen using concentrated photovoltaic technology. The company was founded in 2018 and is headquartered in Dublin, Ireland.

Fusion Fuel Green Ltd - Ordinary Shares - Class A

Fusion Fuel Green PLC

HTOO is trending due to news of a non-binding term sheet for a strategic partnership focused on hydrogen infrastructure investments, sparking discussions about its low float and potential for a squeeze. While some express skepticism given the company's history, others are optimistic about the partnership's prospects and the potential for significant gains. The community is actively debating whether HTOO can maintain its momentum and break through resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High?

The consensus price target hints at an 831.4% upside potential for Cybin Inc. (CYBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Shares of Cybin, Inc. (<a class="mention" data-mention="$CYBN" data-symbol-id="CYBN" href="https://stocktwits.com/symbol/CYBN" target="_blank">$CYBN</a>) surged as much as 10% on Monday, reaching their highest level since May, following the announcement of “unprecedented” 12-month efficacy data from a Phase 2 study of the biopharma’s major depressive disorder (MDD) treatment.The company reported that two 16 mg doses of CYB003, a proprietary deuterated psilocin program, spaced three weeks apart, showed “consistent, robust, and sustained” treatment benefits through the 12-month follow-up.&nbsp;This data supports the potential of CYB003 as an adjunctive treatment for MDD patients who have not achieved remission with first-line antidepressants, Cybin said.The U.S. Food and Drug Administration (FDA) recently granted CYB003 Breakthrough Therapy Designation, accelerating its review process.Cybin’s CEO, Doug Drysdale, noted that the results validate the company’s approach and could revolutionize the standard of care in MDD treatment.&nbsp;“We are quite possibly witnessing a watershed moment in mental health care treatment paradigms and practices,” he said.Drysdale emphasized that current treatments, such as esketamine and electroconvulsive therapy (ECT), require up to 36 outpatient visits per treatment cycle, creating a significant burden on both patients and healthcare facilities.&nbsp;In contrast, CYB003’s two-dose treatment regimen could offer a more patient-friendly, long-lasting alternative.On Stocktwits, retail sentiment for CYBN turned ‘extremely bullish,’ with users expressing optimism about the future of the company and its potential impact on mental health care.&nbsp;Some users pointed to potential regulatory support under a Trump administration, suggesting that prominent figures like Robert F. Kennedy Jr. as HHS Secretary could expedite FDA approval for CYB003.<stembedurl>https://stocktwits.com/PsychedStocks/message/592985335</stembedurl>Another hoped that the stock would double to $25 soon.&nbsp;<stembedurl>https://stocktwits.com/DJTHollaAtMe/message/593002464</stembedurl>Analyst firms remain optimistic, even as Canaccord maintained a ‘Buy’ rating while lowering its price target to $86 from $96 last week.&nbsp;Alliance Global Partners, meanwhile, raised its target to $25 from $6, reflecting the potential upside based on CYB003’s progress and ongoing Phase 3 trials.Still, Cybin’s stock has seen a 19% decline year-to-date.&nbsp;For updates and corrections, email newsroom@stocktwits.comRead next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lbrt-stock-rises-as-ceo-to-join-trump-cabinet/cJ4vdwSRQe">Liberty Energy Stock Pops Following CEO’s Nomination To Trump’s Cabinet: Retail Buzz Grows</a>

The U.S. Food and Drug Administration (FDA) recently granted Cybin's CYB003 Breakthrough Therapy Designation, accelerating its review process.

Cybin Stock In Focus On MDD Treatment's 'Breakthrough’ Efficacy: Retail Turns Extremely Bullish

Cybin's CEO, Doug Drysdale, noted that the results validate the company’s approach and could revolutionize the standard of care in MDD treatment.

Equity

Cybin’s CEO, Doug Drysdale, noted that the results validate the company’s approach and could revolutionize the standard of care in MDD treatment.

How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition

How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder (GAD) Condition How Psychedelic-Based Therapeutics Are Advancing in Treating Generalized Anxiety Disorder...

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Cybin Inc

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

CYBN
Cybin Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CYBN News

CYBN Cybin Inc